Loading organizations...
Loading organizations...
Developing oral recombinant protein vaccines and antiviral treatments.
Vaxart has raised $30.9M across 2 funding rounds.
Vaxart has raised $30.9M in total across 2 funding rounds.
Vaxart has raised $30.9M in total across 2 funding rounds.
Vaxart's investors include Richard Markham, Jan Leschly.
Vaxart has raised $30.9M across 2 funding rounds. Most recently, it raised $18.4M Other Equity in January 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 8, 2015 | $18.4M Other Equity | Richard Markham | |
| Mar 4, 2010 | $12.5M Series B | Jan Leschly |